Perrigo (PRGO) EBITDA Margin Growth (3y) (2016 - 2026)
Perrigo (PRGO) EBITDA Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | -246.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -246.00 |
| Mar 28, 2026 | -4,252.00 |
| Dec 31, 2025 | -11,868.00 |
| Sep 27, 2025 | 395.00 |
| Jun 28, 2025 | 491.00 |
| Mar 29, 2025 | 247.00 |
| Dec 31, 2024 | 581.00 |
| Sep 28, 2024 | -3,464.00 |
| Jun 29, 2024 | 1,035.00 |
| Mar 30, 2024 | -1,019.00 |
| Dec 31, 2023 | -426.00 |
| Sep 30, 2023 | -230.00 |
| Jul 1, 2023 | -185.00 |
| Apr 1, 2023 | -387.00 |
| Dec 31, 2022 | 548.00 |
| Oct 1, 2022 | -156.00 |
| Jul 2, 2022 | -540.00 |
| Apr 2, 2022 | -669.00 |
| Dec 31, 2021 | -477.00 |
| Oct 2, 2021 | 5,280.00 |